BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27120784)

  • 1. Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.
    Lupini L; Pepe F; Ferracin M; Braconi C; Callegari E; Pagotto S; Spizzo R; Zagatti B; Lanuti P; Fornari F; Ghasemi R; Mariani-Costantini R; Bolondi L; Gramantieri L; Calin GA; Sabbioni S; Visone R; Veronese A; Negrini M
    Oncotarget; 2016 May; 7(21):31361-71. PubMed ID: 27120784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-30e-3p Influences Tumor Phenotype through
    Gramantieri L; Pollutri D; Gagliardi M; Giovannini C; Quarta S; Ferracin M; Casadei-Gardini A; Callegari E; De Carolis S; Marinelli S; Benevento F; Vasuri F; Ravaioli M; Cescon M; Piscaglia F; Negrini M; Bolondi L; Fornari F
    Cancer Res; 2020 Apr; 80(8):1720-1734. PubMed ID: 32015093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-589-5p inhibits MAP3K8 and suppresses CD90
    Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma.
    Wan Y; Cui R; Gu J; Zhang X; Xiang X; Liu C; Qu K; Lin T
    Oxid Med Cell Longev; 2017; 2017():5189138. PubMed ID: 28811864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X; Chen GQ; Cao GM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.
    Chen F; Zhu HH; Zhou LF; Wu SS; Wang J; Chen Z
    Oncol Rep; 2010 May; 23(5):1457-62. PubMed ID: 20372864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of miR-211-5p in hepatocellular carcinoma metastasis by targeting ZEB2.
    Jiang G; Wen L; Deng W; Jian Z; Zheng H
    Biomed Pharmacother; 2017 Jun; 90():806-812. PubMed ID: 28437884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
    Wang JT; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J; Xu T; Wang F; Cai W; Chen L
    Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-27a-3p inhibits cell viability and migration through down-regulating DUSP16 in hepatocellular carcinoma.
    Li JM; Zhou J; Xu Z; Huang HJ; Chen MJ; Ji JS
    J Cell Biochem; 2018 Jul; 119(7):5143-5152. PubMed ID: 29143999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
    Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
    Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma.
    Gu Y; Ji F; Liu N; Zhao Y; Wei X; Hu S; Jia W; Wang XW; Budhu A; Ji J; Zhao B; Roessler S; Zheng X; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):268. PubMed ID: 33256802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor role of miR-4782-3p in hepatocellular carcinoma.
    Bo W; Hu Y; Feng X; Zhang H; Tian L; Liu A
    Oncol Rep; 2016 Apr; 35(4):2107-12. PubMed ID: 26782643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
    Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
    Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.